Indivi to Collaborate with Biogen to Advance Digital Health Technology and Digital Biomarkers for Parkinson’s Disease
Digital Health Global
MARCH 26, 2024
Through this collaboration, Indivi will take over the digital management of Konectom TM in the Phase 2b LUMA study evaluating the efficacy and safety of BIIB122 in participants with early-stage Parkinson’s disease, which is being developed in collaboration with Denali Therapeutics Inc.
Let's personalize your content